Clarification on the news article by Commercial Times

Date of occurrence: June 29, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A Name of mass media: Page B4 of Commercial Times Content reported: Commercial Times reported that “…The IND for OBI-888 will be obtained by the end of the year […]

This article is password protected.

To view the content, please enter your password in the field below